• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNVISC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNVISC Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problems Fatigue (1849); Pain (1994); Complaint, Ill-Defined (2331); Sweating (2444); Ambulation Difficulties (2544)
Event Date 01/06/2015
Event Type  Injury  
Event Description
I received synvisc knee injections on (b)(6) 2015 and have had extreme and significant increasing pain and intolerance to walking or event touching my knees.I assumed this was a normal progression of arthritis and was not going to benefit from synvisc.After reading online, other consumer adverse reports similar to my experience, i now realize that my high pain tolerance may have delayed my reporting to the fda and i should have reported this as an emergency situation to my physician.After the injection i became extremely fatigued to the point of nodding off to sleep while driving home from the doctor's office.I was barely able to pull off the highway and fell asleep for a short time.I then drove through a fast food establishment for fluids and food, then rested in a parking lot.I later attempted to drive home and periodically pulled over to rest before arriving home.After arrival, i iced and elevated my knees for 3 days.This was later reported to synvisc and i was told this has never been reported in the past (fatigue from injection).Thereafter when walking more than a few minutes i have broken out in a sweat and can only tolerate walking for a few minutes.The doctor's office and synvisc indicated it may take time for improvement after this injection.I feel that this medication has caused me significant medical issues and my delay in further treatment may have caused me severe permanent damage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC
Type of Device
SYNVISC
MDR Report Key4739645
MDR Text Key5707362
Report NumberMW5042392
Device Sequence Number1
Product Code MOZ
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 04/26/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/26/2015
Patient Sequence Number1
Treatment
RX MEDS: BENICAR; ELESTRIN; MOBIC SPIRONALACTONE; SULFASAZLINE; FOLIC ACID; SYNTHROID; ONE-A-DAY MULTIPLE VITAMIN; OTC MEDS: OSCAL 500
Patient Outcome(s) Disability;
Patient Age58 YR
Patient Weight82
-
-